Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: A new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?

Basic Research in Cardiology

Volumn 104, Issue 1, 2009, Pages 69-77

  Pantos, Constantinos ^a   Mourouzis, Iordanis ^a   Saranteas, Theodosios ^a   Clavé, Guillaume ^b   Ligeret, Heidi ^b   Noack Fraissignes, Pauline ^b   Renard, Pierre Yves ^c   Massonneau, Marc ^b   Perimenis, Philipos ^a   Spanou, Danai ^a   Kostopanagiotou, Georgia ^a   Cokkinos, Dennis V ^d,e  

^a UNIVERSITY OF ATHENS   (Greece)

^b Quidd Saint Etienne du Rouvray   (France)

^c UNIVERSITÉ DE ROUEN   (France)

^d ONASSIS CARDIAC SURGERY CENTER   (Greece)

^e BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Apoptosis; Caspase 3; Inotropes; Ischaemia reperfusion; MAPKs; Myocardial infarction; Thyroxine

Indexed keywords

CASPASE 3; LACTATE DEHYDROGENASE; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; THYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FLUORESCENCE ANALYSIS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; BIOMECHANICS; CASPASE 3; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEART; HEART VENTRICLES; HEMODYNAMICS; L-LACTATE DEHYDROGENASE; PROTEINS; RATS; REPERFUSION INJURY; TRIIODOTHYRONINE; VENTRICULAR FUNCTION, LEFT;

EID: 57949091223     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-008-0758-4     Document Type: Article

References (34)

1. Chen YF, Kobayashi S, Chen J, Redetzke RA, Said S, Liang Q, Gerdes AM (2008) Short term triiodo-l-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats. J Mol Cell Cardiol 44:180-187
2. Davis PJ, Davis FB (2002) Nongenomic actions of thyroid hormone on the heart. Thyroid 12:459-466
3. Du Toit EF, Muller CA, McCarthy J, Opie LH (1999) Levosimendan: Effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther 290:505-514
4. du Toit EF, Opie LH (1992) Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res 70:960-967
5. Dyke CM, Ding M, Abd-Elfattah AS, Loesser K, Dignan RJ, Wechsler AS, Salter DR (1993) Effects of triiodothyronine supplementation after myocardial ischemia. Ann Thorac Surg 56:215-222
6. Dyke CM, Yeh T, Jr., Lehman JD, Abd-Elfattah A, Ding M, Wechsler AS, Salter DR (1991) Triiodothyronine-enhanced left ventricular function after ischemic injury. Ann Thorac Surg 52:14-19
7. Engelbrecht AM, Niesler C, Page C, Lochner A (2004) p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res Cardiol 99:338-350
8. Fischer P, Hilfiker-Kleiner D (2007) Survival pathways in hypertrophy and heart failure: The gp130-STAT axis. Basic Res Cardiol 102:393-411
9. Frantz S, Hu K, Adamek A, Wolf J, Sallam A, Kg Maier S, Lonning S, Ling H, Ertl G, Bauersachs J (2008) Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol 103:485-492
10. Gallagher G, Menzie S, Huang Y, Jackson C, Hunyor SN (2007) Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep. Basic Res Cardiol 102:63-72
11. Halkos ME, Zhao ZQ, Kerendi F, Wang NP, Jiang R, Schmarkey LS, Martin BJ, Quyyumi AA, Few WL, Kin H, Guyton RA, Vinten-Johansen J (2008) Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol 103:525-536
12. Hausenloy DJ, Yellon DM (2007) Reperfusion injury salvage kinase signalling: Taking a RISK for cardioprotection. Heart Fail Rev 12:217-234
13. Kadletz M, Mullen PG, Ding M, Wolfe LG, Wechsler AS (1994) Effect of triiodothyronine on postischemic myocardial function in the isolated heart. Ann Thorac Surg 57:657-662
14. Khoynezhad A, Jalali Z, Tortolani AJ (2004) Apoptosis: Pathophysiology and therapeutic implications for the cardiac surgeon. Ann Thorac Surg 78:1109-1118
15. ++ sensitivity in normal and stunned myocardium of isolated rabbit hearts. Basic Res Cardiol 89:549-562
16. Korngold EC, Jaffer FA, Weissleder R, Sosnovik DE (2008) Noninvasive imaging of apoptosis in cardiovascular disease. Heart Fail Rev 13:163-173
17. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL (1999) Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99:1685-1691
18. Miura T, Miki T (2008) Limitation of myocardial infarct size in the clinical setting: Current status and challenges in translating animal experiments into clinical therapy. Basic Res Cardiol 103:501-513
19. Novitzky D, Cooper DK, Swanepoel A (1989) Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: An initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg 3:140-145
20. Novitzky D, Matthews N, Shawley D, Cooper DK, Zuhdi N (1991) Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg 51:10-16; discussion 16-17
21. Pantos C, Malliopoulou V, Mourouzis I, Thempeyioti A, Paizis I, Dimopoulos A, Saranteas T, Xinaris C, Cokkinos DV (2006) Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70. Horm Metab Res 38:308-313
22. Pantos C, Malliopoulou V, Paizis I, Moraitis P, Mourouzis I, Tzeis S, Karamanoli E, Cokkinos DD, Carageorgiou H, Varonos D, Cokkinos DV (2003) Thyroid hormone and cardioprotection: Study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol Cell Biochem 242:173-180
23. Pantos C, Mourouzis I, Cokkinos DV (2006) Myocardial ischemia: Basic concepts. In: Cokkinos DV, Pantos C, Heusch G, Taegtmeyer H (eds) Myocardial ischemia: From mechanisms to theurapeutic potentials. Springer, New York, pp 11-77
24. Pantos C, Mourouzis I, Dimopoulos A, Markakis K, Panagiotou M, Xinaris C, Tzeis S, Kokkinos AD, Cokkinos DV (2007) Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction. Basic Res Cardiol 102:327-333
25. Pantos C, Mourouzis I, Markakis K, Tsagoulis N, Panagiotou M, Cokkinos DV (2008) Long-term thyroid hormone administration re-shapes left ventricular chamber and improves cardiac function after myocardial infarction in rats. Basic Res Cardiol 103(4):308-318
26. Pantos C, Mourouzis I, Tzeis S, Moraitis P, Malliopoulou V, Cokkinos DD, Carageorgiou H, Varonos D, Cokkinos D (2003) Dobutamine administration exacerbates postischaemic myocardial dysfunction in isolated rat hearts: an effect reversed by thyroxine pretreatment. Eur J Pharmacol 460:155-161
27. Pantos C, Mourouzis I, Xinaris C, Cokkinos DV (2008) Thyroid hormone and myocardial ischaemia. J Steroid Biochem Mol Biol 109:314-322
28. Pantos CI, Malliopoulou VA, Mourouzis IS, Karamanoli EP, Paizis IA, Steimberg N, Varonos DD, Cokkinos DV (2002) Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid 12:325-329
29. Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, Keogh BE, Mascaro J, Riddington DW, Rooney SJ, Townend JN, Wilson IC, Bonser RS (2006) Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation 114:I245-I250
30. Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M (2001) Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res 88:175-180
31. Suga H, Hisano R, Goto Y, Yamada O, Igarashi Y (1983) Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle. Circ Res 53:306-318
32. Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, Matsunari I, Nakajima K, Tonami N, Strauss HW (2004) Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V. J Nucl Med 45:1536-1541
33. 2 consumption in normal human heart: Effects of dobutamine. Am J Physiol 265:H1884-H1892
34. Zinman T, Shneyvays V, Tribulova N, Manoach M, Shainberg A (2006) Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes. J Cell Physiol 207:220-231